Similar Papers

Paper Title
Journal
Date
Author
Cost-effectiveness of enzyme replacement therapy for type 1 Gaucher disease.
Laura Van Dussen ... Marcel Gw Dijkgraaf
Orphanet Journal of Rare Diseases | VOL. 9
Laura Van Dussen, et. al.Laura Van Dussen ... Marcel Gw Dijkgraaf
14 Apr 2014
The cost-effectiveness of enzyme replacement therapy (ERT) for the infantile form of Pompe disease: comparing a high-income country's approach (England) to that of a middle-income one (Colombia)
Héctor E Castro- Jaramillo
Revista de Salud Pública | VOL. 14
Héctor E Castro- JaramilloHéctor E Castro- Jaramillo
01 Feb 2012
Cost-effectiveness of enzyme replacement therapy for Fabry disease
Saskia M Rombach ... Carla Em Hollak
Orphanet Journal of Rare Diseases | VOL. 8
Saskia M Rombach, et. al.Saskia M Rombach ... Carla Em Hollak
19 Feb 2013
Cost-effectiveness of Enzyme Replacement Therapy for Fabry Disease
Saskia Rombach ... Carla Hollak
Molecular Genetics and Metabolism | VOL. 105
Saskia Rombach, et. al.Saskia Rombach ... Carla Hollak
19 Jan 2012
View more papers

More From: Health Technology Assessment

Paper Title
Journal
Date
Author
Evidence of quality of life for hospitalised patients with COVID-19: a scoping review.
Edward Jd Webb ... Joanne Euden
Health Technology Assessment | VOL. -
Edward Jd Webb, et. al.Edward Jd Webb ... Joanne Euden
01 May 2024
Establishing a research partnership to investigate functional loss and rehabilitation towards the end of life.
Matthew Maddocks ... Rowan Harwood
Health Technology Assessment | VOL. -
Matthew Maddocks, et. al.Matthew Maddocks ... Rowan Harwood
01 Apr 2024
Prehospital early warning scores for adults with suspected sepsis: the PHEWS observational cohort and decision-analytic modelling study.
Andy Rosser ... Susan J Croft
Health Technology Assessment | VOL. 28
Andy Rosser, et. al.Andy Rosser ... Susan J Croft
01 Mar 2024
Patient-reported outcome measures for monitoring primary care patients with depression: the PROMDEP cluster RCT and economic evaluation.
Adam Wa Geraghty ... Tony Kendrick
Health Technology Assessment | VOL. 28
Adam Wa Geraghty, et. al.Adam Wa Geraghty ... Tony Kendrick
01 Mar 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.